---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-205370"
form_type: "8-K"
ticker: "WHWK"
cik: "0001422142"
company_name: "Whitehawk Therapeutics, Inc."
filed_at: "2024-08-22T23:59:59+00:00"
generated_at: "2026-05-31T08:02:46.468399+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# CMO Loretta Itri resigns; Executive Chairman Neil Desai steps down on Oct 1, 2024

## Summary
- CMO Dr. Loretta Itri voluntarily resigns effective Oct 1, 2024; receives 12 months severance pay plus COBRA reimbursement.
- Executive Chairman Neil Desai terminated effective Oct 1, 2024; receives severance per agreement; remains on board.
- Dr. Itri enters consulting arrangement: 10 hrs/month, $8,000 monthly retainer, initial 3-month term.
- Both executives continue vesting in equity awards during consulting/board service.

## SEC filing metadata
- accession: 0001193125-24-205370
- form_type: 8-K
- ticker: WHWK
- cik: 0001422142
- company_name: Whitehawk Therapeutics, Inc.
- filed_at: 2024-08-22T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1422142/000119312524205370/0001193125-24-205370-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1422142/000119312524205370/d884557d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-205370
- JSON: https://secwatch.observer/filing/0001193125-24-205370.json
- Plain text: https://secwatch.observer/filing/0001193125-24-205370.txt

## Key facts
- Executive change
  Loretta Itri resigned as Chief Medical Officer at Whitehawk Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Medical Officer
  source text: On August 16, 2024, Loretta Itri, M.D. notified the board of directors of the Company (the “Board”) that her employment as Chief Medical Officer will cease effective October 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1422142/000119312524205370/0001193125-24-205370-index.htm
- Executive change
  Neil Desai was terminated as Executive Chairman at Whitehawk Therapeutics, Inc..
  - Action: terminated
  - Role: Executive Chairman
  source text: On August 20, 2024, Neil Desai, Ph.D, was notified that his employment as Executive Chairman of the Company will cease on October 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1422142/000119312524205370/0001193125-24-205370-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.